0001437749-21-009857.txt : 20210427
0001437749-21-009857.hdr.sgml : 20210427
20210427083208
ACCESSION NUMBER: 0001437749-21-009857
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181231
FILED AS OF DATE: 20210427
DATE AS OF CHANGE: 20210427
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tarrabain Alex
CENTRAL INDEX KEY: 0001736937
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55557
FILM NUMBER: 21856030
MAIL ADDRESS:
STREET 1: 18908 89 AVENUE
CITY: EDMONTON
STATE: A0
ZIP: T5T 6B7
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEN BIOTECH INC
CENTRAL INDEX KEY: 0001653821
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
BUSINESS PHONE: 226-344-0660
MAIL ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
5
1
rdgdoc.xml
FORM 5
X0306
5
2018-12-31
0
1
0001653821
CEN BIOTECH INC
CENBF
0001736937
Tarrabain Alex
300-3295 QUALITY WAY
WINDSOR, ONTARIO, CANADA
A6
N8T 3R9
ONTARIO, CANADA
1
1
Chief Financial Officer*
Common Stock
2018-01-14
4
J
0
L
3000
0
A
114571
D
Common Stock
2018-02-14
4
J
0
L
3000
0
A
114571
D
Common Stock
2018-03-15
4
J
0
L
3000
0
A
114571
D
Common Stock
2018-04-17
4
J
0
L
3000
0
A
114571
D
Common Stock
2018-05-14
4
J
0
L
3000
0
A
114571
D
Common Stock
2018-06-15
4
J
0
L
3000
0
A
114571
D
Common Stock
2018-07-16
4
J
0
L
3000
0
A
114571
D
Common Stock
2018-08-16
4
J
0
L
3000
0
A
114571
D
Common Stock
2018-09-16
4
J
0
L
3000
0
A
114571
D
Common Stock
2018-10-16
4
J
0
L
3000
0
A
114571
D
Common Stock
2018-11-20
4
J
0
L
3000
0
A
114571
D
Common Stock
2018-12-14
4
J
0
L
3000
0
A
114571
D
36,000 shares of common stock of the issuer were issued from January 14, 2018 to December 14, 2018 as interest pursuant to agreeing to extend the maturity date of a promissory note which was issued on January 14, 2018 in the amount of $75,000.
Includes 30,000 shares issuable upon conversion of a convertible promissory note held by the reporting person which was issued on October 26, 2016 in the amount of $48,000.
*On July 12, 2017, Alex Tarrabain (the "Reporting Person") was appointed as a director of the issuer. On May 21, 2019, the Reporting Person was appointed as the Chief Financial Officer of the issuer.
/s/ Alex Tarrabain
2021-04-27